These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 20203497

  • 1. Overlap between irritable bowel syndrome and inflammatory bowel disease.
    Spiller RC.
    Dig Dis; 2009; 27 Suppl 1():48-54. PubMed ID: 20203497
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F, Perelló A, Balboa A.
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [Abstract] [Full Text] [Related]

  • 4. Infection, inflammation, and the irritable bowel syndrome.
    Spiller R, Garsed K.
    Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778
    [Abstract] [Full Text] [Related]

  • 5. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M, Herfarth H, Drossman DA.
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [Abstract] [Full Text] [Related]

  • 6. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
    Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, Peyron JF, Czerucka D, Cherikh F, Filippi J, Tran A, Hébuterne X.
    Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
    [Abstract] [Full Text] [Related]

  • 7. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM, Denou E, Verdu EF, Bercik P.
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [Abstract] [Full Text] [Related]

  • 8. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 9. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [Abstract] [Full Text] [Related]

  • 10. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
    Jones MP, Bratten J, Keefer L.
    Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
    [Abstract] [Full Text] [Related]

  • 11. 'I feel as if my IBS is keeping me hostage!' Exploring the negative impact of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) upon university-aged women.
    Schneider MA, Fletcher PC.
    Int J Nurs Pract; 2008 Apr; 14(2):135-48. PubMed ID: 18315827
    [Abstract] [Full Text] [Related]

  • 12. Postinfectious irritable bowel syndrome.
    Spiller R, Garsed K.
    Gastroenterology; 2009 May; 136(6):1979-88. PubMed ID: 19457422
    [Abstract] [Full Text] [Related]

  • 13. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
    Jones MP, Wessinger S, Crowell MD.
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
    [Abstract] [Full Text] [Related]

  • 14. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
    Quigley EM.
    Chin J Dig Dis; 2005 Apr; 6(3):122-32. PubMed ID: 16045602
    [Abstract] [Full Text] [Related]

  • 15. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Fronzoni L, Serra M, Corinaldesi R.
    Dig Dis; 2009 Apr; 27 Suppl 1():115-21. PubMed ID: 20203507
    [Abstract] [Full Text] [Related]

  • 16. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A, Nijkamp FP, Kraneveld AD.
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [Abstract] [Full Text] [Related]

  • 17. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut?
    Camilleri M.
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S46-8. PubMed ID: 19300123
    [Abstract] [Full Text] [Related]

  • 18. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M, Guilarte M, Alonso C, Yang P, Martínez C, Ramos L, Lobo B, González A, Guilà M, Pigrau M, Saperas E, Azpiroz F, Santos J.
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [Abstract] [Full Text] [Related]

  • 19. Postinfectious irritable bowel syndrome.
    Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R.
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138
    [Abstract] [Full Text] [Related]

  • 20. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
    Vivinus-Nébot M, Dainese R, Anty R, Saint-Paul MC, Nano JL, Gonthier N, Marjoux S, Frin-Mathy G, Bernard G, Hébuterne X, Tran A, Theodorou V, Piche T.
    Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.